“It is always an honor to receive this award. Helping my patients attain relief from the discomfort of TMJ and/or sleep apnea is so rewarding” says Dr. Bob Perkins.

MALIBU, Calif. (PRWEB)
June 01, 2023

With over 30 years of experience treating TMJ disorders, as well as cosmetic and restorative dentistry to correct the bite and realign the jaw, Dr. Bob Perkins has been a trusted dentist for countless patients. He has been selected for this distinguished award from Find Local Doctors as a result of his exceptional patient reviews and five-star ratings across multiple online sources. Find Local Doctors is an online directory that helps consumers quickly locate qualified and reputable physicians and dentists in their area. Dr. Bob Perkins is widely known as a true pioneer and expert in his field, and one of the best neuromuscular dentists in the country. He utilizes cutting-edge equipment and the finest materials, techniques and advanced technology to treat temporomandibular disorder (TMJ), sleep apnea and other issues. Dr. Perkins has significant training and experience to help determine the root cause of the problem. He offers effective treatment options, providing relief with unique and efficient repositioning therapies to heal pain in the jaw, neck and teeth relating to TMJ, with the goal of correcting the bite and realigning the jaw to support excellent oral health. Additionally, Dr. Perkins’ continuing education in orthodontics, cosmetic dentistry and facial aesthetics have furthered his commitment to helping his patients obtain proportional facial structures, non-constricted pathways and life without TMJ pain. Creating and supporting healthy and beautiful smiles is what he is most passionate about, and it shows with his large number of satisfied patients.

“It is always an honor to receive this award. Helping my patients attain relief from the discomfort of TMJ and/or sleep apnea is so rewarding” says Dr. Bob Perkins.

More About Dr. Bob Perkins:

A recognized leader, author and specialist in the field of TMJ, Dr. Bob Perkins began his undergraduate educational training at the University of Southern California. He then attended the Las Vegas Institute for Advanced Dental Studies, where he furthered his knowledge in cosmetic dentistry, orthodontics and TMJ disorders. Dr. Perkins is an expert in the field of TMD/TMJ and uses state-of-the-art equipment, techniques and up-to-date science to treat temporomandibular disorder. His treatments offer immediate relief from any stress or pain patients experience with the goal of correcting the bite and realigning the jaw in support of excellent oral health. Southern California TMJ and Sleep Clinic has three clinic locations in California. The offices are located in Malibu – (24955 Pacific Coast Highway, Ste. C100), Studio City – (12412 Ventura Blvd., Suite 1 ) and San Diego – (450 A Street #410.) For more information or to schedule a consultation, please visit http://www.socaltmjandsleepcenter.com or call 323-924-3790.

Share article on social media or email:

“I am thrilled for the opportunity to foster long-lasting relationships with my patients and help them achieve their dental health goals at Autumn Dental,” says Dr. Nicole Barnett.

MARIETTA, Ga. (PRWEB)
June 01, 2023

Autumn Dental provides those in the Marietta and greater Atlanta area with exceptional, personalized dentistry for the entire family. Dr. Nicole Barnett and her team deliver a warm and friendly dental experience and strive to exceed each patient’s expectations. Dr. Barnett has been treating patients at the office for the past two and a half years and is excited to continue to offer the same premier level of comprehensive dental care under the new practice name. Autumn Dental has a wide menu of services for patients, including general dentistry, cosmetic dentistry, and restorative dentistry and is equipped for those with special needs and dental anxiety. Dr. Barnett utilizes state-of-the-art dental technology and cutting-edge procedures in order to help her clients maintain healthy, attractive smiles. When it comes to dentistry, Autumn Dental’s ultimate goal is to make sure clients feel as comfortable as possible and make receiving the oral health care they need convenient.

“I am thrilled for the opportunity to foster long-lasting relationships with my patients and help them achieve their dental health goals at Autumn Dental,” says Dr. Nicole Barnett.

More about Dr. Nicole Barnett:

Dr. Nicole Barnett attended Auburn University, graduating summa cum laude with a degree in Biomedical Sciences. While there, she was a member of the Auburn University Gymnastics Team and was named SEC Scholar-Athlete of the Year and NCAA Academic All-American. Dr. Barnett attended dental school at the Medical College of Georgia in Augusta and was the recipient of the Hinman Dental Society Scholarship and Judson C. Hickey Memorial Scholarship. From there, she went on to complete additional training in a General Practice Residency at the University of Tennessee Medical Center in Knoxville. During her residency, she did rotations in oral and maxillofacial surgery, forensic dentistry, family medicine, anesthesiology and emergency medicine. While there, Dr. Barnett also gained valuable experience treating patients with dental phobias and special needs, handling dental emergencies in the ER, managing complex dental treatments, and treating patients in the OR under general anesthesia. After completing her residency, she moved to Atlanta and has been practicing as a general dentist for over a decade. For additional information about the dental services at Autumn Dental or to schedule an appointment please call (770) 980-6336 and visit http://www.AutumnDental.com.

Share article on social media or email:

Advantage Gold Founder Adam Baratta

“Without Adam Advantage Gold simply would not exist. It is because of his vision, passion, and leadership, that we have become the gold standard in the industry,” said CEO Kirill Zagalsky.

MEADOWBROOK, Pa. (PRWEB)
June 01, 2023

Adam Baratta, the co-founder of Advantage Gold and Brentwood Research, has announced that he will be stepping down from his role of Managing Partner of each entity to pursue new opportunities. Baratta expressed his gratitude to his entire team for their support and hard work, which has been the main driver of the company’s success over the last nine years.

Baratta built Advantage Gold into the leading precious metals dealer in the United States with his unwavering commitment to education and superior customer service. “Advantage Gold was founded on the fundamental belief that there was a better way to operate in the precious metals industry,” Baratta said. “Looking back on the past nine years, I am filled with immense pride at the progress we have made. The AG family has remained resolute in our commitment to delivering exceptional value, which has propelled us to the forefront of the industry and earned us the ranking as the highest-rated firm in the country. As I depart, I am confident that the company will continue to build on its momentum and achieve even greater success.”

Under his leadership, Baratta transformed the start-up publishing firm Brentwood Research into one of the fastest-growing financial publishers in the country, producing two #1 national bestselling books, Gold Is A Better Way and The Great Devaluation. He has a passion for this storytelling that he intends to expand upon in the next stage of his career.

“As a writer and content producer, I hold the view that we must be free to explore diverse ideas that go beyond the confines of a single subject,” said Adam Baratta. “I am excited about expanding my writing scope beyond finance to provide valuable storytelling that can help us navigate through the complexities of the present era.”

CEO Kirill Zagalsky expressed his appreciation for Adam’s contributions to the company and wished him well in his new pursuits. “Without Adam Advantage Gold simply would not exist. It is because of his vision, passion, and leadership, that we have become the gold standard in the industry. Adam will forever be a loved and admired member of the Advantage Gold family. We wish him all the best in his future endeavors,” said Zagalsky.

Advantage Gold will continue to focus on its mission of providing “the best process, the best service, and the best value” in the precious metals industry.

Share article on social media or email:

We’re excited to be modernizing our validation approach at Greenlight Guru because it will allow us to release software faster and improve the pace of innovation without jeopardizing compliance for our customers.

INDIANAPOLIS (PRWEB)
June 01, 2023

Greenlight Guru, the leading provider of cloud-based software for MedTech companies, today announced that it is adopting an automated, risk-based approach to software validation and strategically updating its Software Validation Package for customers. The modernized approach is in line with FDA guidance on Computer Software Assurance (CSA) and requirements of ISO 13485:2016 to ease the burden of validating new software for MedTech companies.

In the 2023 MedTech Industry Benchmark Report, one of the top challenges cited for managing quality was the cost and effort of validating new software tools and processes. This is mainly due to the more cumbersome approach to software validation—known as computer system validation (CSV)—that has traditionally been used in MedTech to meet regulatory requirements.

In 2022, FDA released a draft guidance, Computer Software Assurance for Production and Quality System Software, as part of a greater, industry-wide shift toward a more balanced approach to software validation for MedTech companies. This new approach will make it easier for MedTech companies to adopt new technology and explore the full potential of software tools for their businesses.

“The shift from CSV to CSA is a move toward a more balanced, risk-based approach to software validation,” says Brian Gaffney, CTO of Greenlight Guru. “We’re excited to be modernizing our validation approach at Greenlight Guru because it will allow us to release software faster and improve the pace of innovation without jeopardizing compliance for our customers. It also streamlines the implementation of our QMS solution for customers, which is a win for everyone.”

In light of the shift to CSA, Greenlight Guru’s Validation Package has been strategically updated to align with the best practices and requirements in the FDA’s guidance on Computer Software Assurance and ISO/TR 80002-2:2017, Validation of software for medical device quality systems. The Validation Package will enable teams to efficiently and effectively implement and adopt the latest software enhancements and functionality while assuring compliance with evolving validation requirements.

“Modernizing our validation processes helps ensure we’re doing everything possible to help our customers easily implement Greenlight Guru and get their life-changing medical devices to the patients who need them most,” says David DeRam, CEO of Greenlight Guru. “Ultimately, this shift is about helping MedTech companies keep up with evolving industry requirements and focus their resources where they matter most.”

When asked about the benefits of the updated Software Validation Package, Greenlight Guru customer Mary Head, ISO 13485:2016 Lead Auditor and Document Control Team Lead at DNAe, shared the following:

“The vast majority of software platforms are not built for medical device companies and therefore require painstakingly hard and time-consuming validation processes. With Greenlight Guru, we do not have to do any of that. We are excited about this shift in the industry and it is such a value-add to partner with innovative companies like Greenlight Guru who are at the forefront of this evolution and making software validation even easier for medical device companies.”

This announcement of an updated software validation approach comes on the heels of Greenlight Guru’s recent launch of Risk Solutions, a first-of-its-kind complete risk management solution that leverages AI-generated insights with intuitive workflows aligned with ISO 14971:2019.

To learn more about Greenlight Guru’s approach to software validation, visit https://www.greenlight.guru/medical-device-software-validation.

About Greenlight Guru

Greenlight Guru provides the leading cloud-based solutions for MedTech companies to bring life-changing products to people faster, and with less risk. Greenlight Guru provides purpose-built quality management, product development, and clinical data management solutions that together help teams accelerate timelines, streamline compliance, and deliver high-quality products. With Greenlight Guru, companies across the globe are improving efficiency, speed, and quality in every aspect of their organization to get products to market faster and keep them on the market longer. For more information, visit http://www.greenlight.guru.

Media Contact

PR at Greenlight Guru

pr@greenlight.guru

Share article on social media or email:

“With a mission to bolster the economic vitality of our state, the BEA is constantly seeking opportunities to provide increased support to our valued partners and key industry sectors,” says Taylor Caswell, commissioner at BEA.

CONCORD, N.H. (PRWEB)
June 01, 2023

The New Hampshire Department of Business and Economic Affairs (BEA) today announced the findings of a statewide life sciences industry assessment, which found that the state’s life science workforce added 1,484 jobs, representing a 15.1% growth rate within the industry and 3.8% of the state’s total job growth between 2012 and 2021. To further ensure growth and support the $2.8 billion sector, the BEA conducted a comprehensive assessment of New Hampshire’s life science sector. One of the findings was that the state would benefit from a life science association to nurture, protect and grow the industry, while providing networking, talent attraction and mentorship opportunities for life science companies, entrepreneurs and students.

The Camoin Associates study found that the life sciences industry saw $4.3 billion in sales in 2021 and represents 11,290 jobs, with average salaries of $130,848 per year. The industry’s top group is medical device manufacturing, with 31% of all life science jobs, followed by research and development services (26%), medical equipment and supplies manufacturing (23%), pharmaceutical and medicine manufacturing (16%) and medical and diagnostic laboratories (4%).

“With a mission to bolster the economic vitality of our state, the BEA is constantly seeking opportunities to provide increased support to our valued partners and key industry sectors,” says Taylor Caswell, commissioner at BEA. “This new strategy will help make our life sciences sector even more robust – allowing for workforce growth, strengthened partnerships and igniting fresh innovations within this thriving industry.”

The report reinforces the need for a New Hampshire-based life sciences industry association to drive peer-level sector support, recruitment and advocacy. Thanks to leading industry partners, this concept has been in development for the past several years and has now officially launched as New Hampshire Life Sciences (NHLS).

The report will also serve as the basis for a new series of strategies to support the industry’s growth. They include continued outreach regarding relevant market data, forging cross-industry workforce partnerships, establishing acceleration and incubator programs to address workforce gaps, and expanding marketing communications to amplify the industry.

“Right here in New Hampshire, an entirely new industry in biomanufacturing is being created, innovative treatments for the world’s deadliest cancers are transforming patient care, and vaccines that are preventing disease around the globe are being developed,” said Andrea Hechavarria, the new president and CEO of the state’s first-ever Life Science Association (NHLS). “NHLS has been formed to support these breakthroughs, the companies and employees that have created them and ultimately the patients that receive them.”

One of the state’s leading life sciences organizations is the Advanced Regenerative Manufacturing Institute (ARMI), a nonprofit focused on the development of large-scale manufacturing of engineered tissues and tissue-related technology. Manchester-based ARMI was awarded a five-year, $51 million grant to boost its efforts. It has since been granted $44 million in Build Back Better funding.

Other notable Granite State life science expansions include Novocure, a global oncology and medical device company that recently announced a $9.5 million expansion in the heart of downtown Portsmouth in 2021. The company ranked second for total industry research and development spending in 2022. This year, Detact Diagnostics, a Netherlands-based life sciences company that produces bacterial- and viral-detection solutions, established its U.S. headquarters and laboratories in Keene. Lonza Biologics (global vaccine manufacturer with operations in Portsmouth) and PCI Pharma Services (a pharmaceutical outsourcing company with operations in Bedford) are both currently in the process of significant expansions of their manufacturing campuses.

“New Hampshire’s vibrant life sciences industry and well-documented innovation climate have always gone hand-in-hand with our company’s patient-forward culture of growth,” said Bill Doyle, executive chairman of Novocure. “We look forward to finishing the construction of our new flagship facility in Portsmouth that will provide space for Novocure’s growing employee base and world-class training and development center. We are proud to play a role in shepherding the continued growth of the Granite State’s robust life sciences community.”

New Hampshire fosters a business-friendly environment where life science companies can benefit from a top-tier workforce, access to an R1 research institution at the University of New Hampshire, and close proximity to the global life science hub in Boston.

To read the full life science industry summary and strategy, please visit https://www.nheconomy.com/about-us/bea-reports.

About the New Hampshire Department of Business and Economic Affairs (BEA)

The Department of Business and Economic Affairs is dedicated to enhancing the economic vitality of the State of New Hampshire while promoting it as a destination for domestic and international visitors. For more information, visit http://www.nheconomy.com or http://www.choosenh.com.

Share article on social media or email:

“I foster trust, empower patients, and promote open communication for shared decision making. I am dedicated to advancing ophthalmology through learning, research, and innovation My goal is to restore and preserve vision, enrich lives, and make a meaningful impact in the lives of people”

MINEOLA, N.Y. (PRWEB)
June 01, 2023

Deepika Malik, MD, a highly experienced and fellowship-trained vitreoretinal surgeon, is ecstatic to join the OCLI Vision team, offering expert eye care services to patients in Rockland County, Orange County, and the boroughs of Queens, Manhattan, and Brooklyn. With her expertise in macular disorders, including age-related macular degeneration, diabetic retinopathy, retinal vein occlusions, inflammatory ocular diseases, and surgical retinal diseases, Dr. Malik has built a well-respected name in the realm of ophthalmology.

Dr. Malik is a Diplomate of the American Board of Ophthalmology and is Board Certified in Ophthalmology. She completed her surgical vitreoretinal fellowship at Gavin Herbert Eye Institute at the University of California, Irvine. Dr. Malik is also a Fellow of the American Society of Retina Specialists, and a member of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Medical Association, and Vit-Buckle Society.

Along with her impressive medical credentials, Dr. Malik is an accomplished researcher and has conducted extensive national clinical trials to analyze the efficacy of drugs and devices in the treatment of retinal disorders. Her devotion to advancing the field of ophthalmology has earned her recognition as a Top Ophthalmologist in the Philadelphia region and inclusion in the 2021 Top Doctors List. Dr Malik has served as Faculty, Department of Ophthalmology, Drexel University College of Medicine; and as Associate Professor, Department of Ophthalmology at Philadelphia College of osteopathic medicine

At her practice, Dr. Malik provides advanced retinal services and the latest diagnostic and treatment options for macular disorders including age-related macular degeneration, retinal vascular diseases, diabetic retinopathy and surgical retinal diseases, such as retinal tears and detachment, tractional retinal detachment, macular pucker, and macular hole. Her practice is affiliated with the New York Eye and Ear Infirmary of Mount Sinai. Dr. Malik is fluent in English as well as Hindi.

“As a retina specialist, I prioritize compassion, precision, and understanding each patient’s unique vision needs. I merge state-of-the-art technology with heartfelt empathy to provide personalized treatment,” noted Dr. Malik.

“My practice philosophy extends beyond the boundaries of the examination room. I am committed to advancing the field of ophthalmology through continuous learning, research, and innovation. By staying at the forefront of scientific advancements, I can offer my patients the latest and most effective treatments available,” Dr. Malik continued.

“I foster trust, empower patients, and promote open communication for shared decision-making. I am dedicated to advancing ophthalmology through learning, research, and innovation My goal is to restore and preserve vision, enrich lives, and make a meaningful impact in the lives of people.”

With Dr. Malik’s expert care, patients can trust that their eye health is in great hands. To schedule an appointment with Dr. Malik, please visit http://www.ocli.net or call 1-866-733-6254

About OCLI Vision

Founded in 1997, OCLI Vision (http://www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.

Share article on social media or email:

“We are very excited and appreciative that Phathom selected Beacon to power their medical affairs activities as they develop innovative treatments for GI-related disorders”, said Dave Gulezian, Co-Founder & CEO of Alucio, “We look forward to ensuring their success with the platform.”

SAN FRANCISCO (PRWEB)
June 01, 2023

Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced that Phathom Pharmaceuticals (Phathom) has selected Alucio’s Beacon platform for use by their Medical Affairs and Field Medical teams. Beacon is a modern content activation and healthcare professionals (HCP) engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals, and Market Access teams.

Through this agreement, Alucio will support Phathom in realizing their scientific exchange objectives as they work to improve the treatment landscape for patients suffering from acid-related gastrointestinal (GI) disorders. Phathom will leverage Beacon’s powerful content library management and on-demand publishing functionality to organize and distribute documents to the MSL team.

Beacon will also compliantly enable MSLs to assemble custom presentations to meet the specific information needs of their Key Opinion Leaders (KOLs). Additionally, Beacon’s hybrid engagement functionality will provide unique, industry-specific features to enrich their virtual meetings across leading video conferencing platforms like Zoom, as well as to power in-person meetings where data service is unavailable.

Through Beacon, Phathom will be able to access relevant content and engagement data through user-friendly reports and dashboards to support its strategic decision making.

Phathom adds to Alucio’s fast-growing roster of life science companies that have become Beacon customers. The platform can support both large and small pharma, biotech, and medical device companies seeking to manage and distribute scientific content more efficiently and to deepen their relationships with both medical KOLs and payers.

“We are very excited and appreciative that Phathom selected Beacon to power their medical affairs activities as they develop innovative treatments for GI-related disorders”, said Dave Gulezian, Co-Founder & CEO of Alucio, “We look forward to ensuring their success with the platform and to deepening our partnership as they move towards commercialization.”

About Alucio:

Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact: Lisa Amin at lamin@alucio.io (925) 788-3533.

Share article on social media or email:

How can providers and payors accelerate their population health transformation when facing increasing costs, an overburdened workforce, and the imperative for more equitable care?

TORONTO (PRWEB)
June 01, 2023

Leading approaches for population health provide a conceptual framework to help understand why some people are healthier than others and how to structure interventions for individuals and groups. How can providers and payors accelerate their population health transformation when facing increasing costs, an overburdened workforce, and the imperative for more equitable care?

Join the featured speakers as they discuss how one hospital system took a project designed to address pandemic surge response and turned it into a platform for addressing significant health inequities.

In this webinar, attendees will learn how to leverage their current healthcare infrastructure- people, data, and technology to improve population health, advance value-based care, and accelerate progress on health equity.

Join Dr. Abdul Shaikh, Global Leader for Population Health, Amazon Web Services; and Dr. Michael Cui, MD, MS, Program Director, Clinical Informatics Fellowship, Assistant Professor, Department of Internal Medicine, Physician Informaticist, Rush University Medical Center, for the live webinar on Monday, June 19, 2023, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Population Health: Leveraging Your Current Healthcare Infrastructure to Accelerate Transformation.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Sinclair

“With a growing demand for non-invasive and minimally invasive aesthetic treatments in Canada, we see a great opportunity to introduce our innovative technologies.” – Andrea Trofimuk, CEO of Sinclair North America

TORONTO (PRWEB)
June 01, 2023

Sinclair is renowned for its high-quality medical aesthetic products, which include both injectable and energy-based systems for facial rejuvenation, body contouring, and skin revitalization. The company’s cutting-edge technology and expertise in the field of medical aesthetics have made it a trusted name in the industry.

Sinclair acquired Viora and Cocoon in recent years expanding their aesthetic business by merging the two energy-based device manufacturers to build a leading portfolio of: radio frequency, IPL, Diode, Cryo and microdermabrasion devices [V-Series, Elysion, Cool Tech, Reaction and Pristine].

The launch of Sinclair North America in Canada is part of the company’s global growth strategy. “We are thrilled to be launching in Canada and expanding our North American footprint. With a growing demand for non-invasive and minimally invasive aesthetic treatments in Canada, we see a great opportunity to introduce our innovative technologies.” said Andrea Trofimuk, CEO of Sinclair North America.

“Our goal is to become a trusted and respected provider of aesthetic solutions in Canada, and we are excited to embark on this new chapter. We are committed to providing quality technology, support and building partnerships throughout Canada, as we have done in the US under the Viora entity for nearly 20 years.” said Gil Shapir, COO of Sinclair North America.

As of September 2021, the aesthetic market size in Canada was valued at approximately CAD 1.3 billion, with a compound annual growth rate (CAGR) of 11.2% from 2019 to 2024 according to a market research report by Mordor Intelligence. The report also forecasted that the market size would continue to grow at a CAGR of 10.3% from 2021 to 2026, reaching a value of approximately CAD 2.1 billion by the end of the forecast period. The growth is attributed to factors such as the increasing demand for minimally invasive and non-invasive procedures, the growing adoption of advanced technologies, and the rising disposable incomes of the population.

About Sinclair

Sinclair is an international company operating in the fast growing, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. Sinclair is planning entry to multiple new geographic markets and line extension launches over the next few years. The Group has an established sales and marketing presence in North America, the EU markets, Brazil, Mexico, Colombia, UAE, Hong Kong and South Korea and a network of international distributors.

Share article on social media or email: